There’s a startup aiming to help aging dogs boost their brain function. And the science might just hold potential for human beings, too.
What’s happening:
- Animal health startup Animal Biosciences has announced the first clinical evidence that their supplement designed to extend lifespan in dogs significantly improves cognitive function in aging dogs
The big idea:
- Animal Biosciences has developed a proprietary chewable supplement that combines a molecule that mimics fasting in an animals body with a molecule that helps combat senescent cells that cause aging
- When these two molecules are combined and metabolized, dogs see a significant improvement in cognitive function as well as other health benefits
Why it matters:
- Therapeutics for improving cognitive function and extending lifespan in animals may provide important insights into longevity science that can also be applied to human beings
Going deeper:
- Animal Biosciences is not the only startup pursuing extending the lifespan of dogs, with Silicon Valley backed biotechnology startup Loyal recently beginning to dose dogs in the first ever clinical trial for their novel therapeutic
The intrigue:
- David Sinclair, who is a professor of genetics at Harvard Medical School and one of the leading minds in longevity science, is a co-founder of Animal Bioscience
